To Evaluate the Safety of DBS in Patients With Primary Parkinson's Disease
To evaluate the safety of implantable rechargeable computer deep nerve stimulation system produced by Jiangsu Changyida Medical Technology Co., Ltd. for patients with primary Parkinson's disease
Aged 18-70 years old, patients with primary Parkinson's disease;2. The duration...
Have received surgical treatment for Parkinson's disease other than deep brain s...